Search hospitals > Michigan > Grosse Pointe
Ascension Saint John Hospital
Claim this profileGrosse Pointe, Michigan 48236
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Leukemia
545 reported clinical trials
15 medical researchers
Summary
Ascension Saint John Hospital is a medical facility located in Grosse Pointe, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Leukemia and other specialties. Ascension Saint John Hospital is involved with conducting 545 clinical trials across 773 conditions. There are 15 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Tareq Al BaghdadiSaint Joseph Mercy Hospital7 years of reported clinical research
Expert in Cancer
Expert in Tumors
70 reported clinical trials
127 drugs studied
Christopher M. Reynolds, MDSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
45 reported clinical trials
99 drugs studied
Philip J. StellaSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
38 reported clinical trials
89 drugs studied
Elie G. DibSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
34 reported clinical trials
94 drugs studied
Clinical Trials running at Ascension Saint John Hospital
Breast Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Gastric Cancer
Bladder Carcinoma
Squamous Cell Carcinoma
Gastroesophageal Junction Adenocarcinoma
Adenocarcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ascension Saint John Hospital?
Ascension Saint John Hospital is a medical facility located in Grosse Pointe, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Leukemia and other specialties. Ascension Saint John Hospital is involved with conducting 545 clinical trials across 773 conditions. There are 15 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Where is Ascension Saint John Hospital located?
Ascension St John Hospital is located at 22101 Moross Rd, Detroit, MI 48236.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Ascension Saint John Hospital:
- **Tulsa, Oklahoma**: Contact the financial counselor at 918-744-3131. For payment and insurance matters, reach out to the Central Business Office at 918-744-2900.
- **Detroit, Michigan**: Contact the financial services department at 313-343-4000.
- Ascension provides financial assistance options for uninsured and underinsured individuals. Visit their website and select your state for more information.
What insurance does Ascension Saint John Hospital accept?
Ascension Saint John Hospital accepts a wide range of insurance plans, including but not limited to BlueAdvantage, BlueCard, BlueChoice PPO, BlueLincs HMO, BlueOptions, BluePreferred, BlueTraditional, Medicare Advantage, Aetna, AvMed, Alignment Healthcare, BeechStreet, Bright Health, CarePlus, and Cigna. It is recommended to verify the hospital's participation with your specific insurance plan before scheduling a visit or procedure.
What awards or recognition has Ascension Saint John Hospital received?
Ascension Saint John Hospital in Grosse Pointe, Michigan, is renowned for its high-quality care, earning several prestigious recognitions:
- Named a Spotlight Hospital by the Oklahoma Perinatal Quality Improvement Collaborative.
- Recognized as an Age-Friendly Health System by the Institute for Healthcare Improvement.
- Accredited by the Commission on Cancer of the American College of Surgeons for its cancer program.
- Ascension St. John Medical Center is Oklahoma’s first certified Transcatheter Valve Center by the American College of Cardiology.
- The Sleep Disorder Center at Ascension St. John Medical Center received a 5-star patient satisfaction award from Professional Research Consultants.